newsfilter
← Latest News
GlobeNewswire·

Prevail Therapeutics to Present at Upcoming Investor Conferences

NEW YORK, Sept. 02, 2020 (GLOBE NEWSWIRE) -- Prevail Therapeutics Inc. (Nasdaq: PRVL), a biotechnology company developing potentially disease-modifying AAV-based gene therapies for patients with...